Company Filing History:
Years Active: 2025
Title: Innovations in Neuroprotection: The Work of Venkatesan Perumal
Introduction
Venkatesan Perumal is an innovative inventor based in Newark, NJ (US). He has made significant contributions to the field of neuroprotection, particularly in the treatment of traumatic brain injury (TBI) and other central nervous system (CNS) diseases. His work focuses on targeted drug delivery systems that enhance therapeutic outcomes while minimizing toxicity.
Latest Patents
Venkatesan Perumal holds a patent for a composition and method involving targeted nanoparticles for the treatment of traumatic brain injury and other CNS diseases. The patent describes a formulation that encapsulates minocycline within nanoparticles, providing a neuroprotective effect in TBI cases. This innovative approach allows for enhanced delivery to the brain and reduced toxicity at minimal dosages. The studies conducted indicate that the nanoparticle-based minocycline formulations effectively cross the blood-brain barrier and achieve a higher therapeutic concentration compared to free minocycline. This advancement offers a promising solution for treating subjects suffering from CNS injuries, including blast-induced traumatic brain injury.
Career Highlights
Venkatesan Perumal is affiliated with the New Jersey Institute of Technology, where he continues to advance his research in neuroprotection and drug delivery systems. His work has garnered attention for its potential to improve treatment outcomes for patients with CNS injuries.
Collaborations
Venkatesan has collaborated with notable colleagues, including Arun Reddy Ravula and Namas Chandra, to further enhance the impact of his research in the field of neuroprotection.
Conclusion
Venkatesan Perumal's innovative work in targeted nanoparticle formulations represents a significant advancement in the treatment of traumatic brain injury and CNS diseases. His contributions are paving the way for safer and more effective therapeutic options in neuroprotection.